Overview

Thyroxine Replacement in Organ Donors

Status:
Completed

Trial end date:
2010-10-01

Target enrollment:

Participant gender:

Summary

To compare oral versus intravenous administration of thyroid hormone: 1) for reversibility of hemodynamic instability in organ donors, and, 2) the pharmacokinetics of oral vs iv thyroid administration

Phase:

Phase 1/Phase 2

Details

Lead Sponsor:

Lawson Health Research Institute